PEMBROKE, BERMUDA, November 5 /CNW/ - Covidien Ltd. (NYSE: COV, BSX: COV)
will report fourth-quarter results before trading begins on December 6, 2007.
The Company will hold a conference call for investors at 8:30 a.m. ET. The
call can be accessed in the following ways:
-- At Covidien's website: http://investor.covidien.com
-- By telephone: For both "listen-only" participants and those
participants who wish to take part in the question-and-answer portion of the
call, the telephone dial-in number in the U.S. is 800-510-0219. For
participants outside the U.S., the dial-in number is 617-614-3451. The access
code for all callers is 92427674.
-- Through an audio replay: A replay of the conference call will be
available beginning at 10:30 a.m. on December 6, 2007 and ending at 11:59 p.m.
on December 13, 2007. The dial-in number for U.S. participants is
888-286-8010. For participants outside the U.S., the replay dial-in number is
617-801-6888. The replay access code for all callers is 43084639.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines, including
Medical Devices, Imaging Solutions, Pharmaceutical Products, Medical Supplies
and Retail Products. With 2006 revenue of nearly $10 billion, Covidien has
more than 43,000 employees worldwide in 57 countries, and its products are
sold in over 130 countries. For additional information, please visit our
For further information:
For further information: Covidien Ltd. Eric Kraus, 508-261-8305 Senior
Vice President Corporate Communications firstname.lastname@example.org or Coleman
Lannum, CFA, 508-452-4343 Vice President Investor Relations
email@example.com or Bruce Farmer, 508-452-4372 Director Financial
Communications firstname.lastname@example.org or Wayde McMillan, 508-452-4387
Director Investor Relations email@example.com